Probiotics, prebiotics, and COVID-19 infection: A review article

dc.creatorKhaled, Jamal M.A.
dc.date.accessioned2020-11-10T15:25:56Z
dc.date.accessioned2022-09-23T18:18:59Z
dc.date.available2020-11-10T15:25:56Z
dc.date.available2022-09-23T18:18:59Z
dc.date.created2020-11-10T15:25:56Z
dc.identifierS1319-562X
dc.identifierhttps://doi.org/10.1016/j.sjbs.2020.11.025
dc.identifierhttp://hdl.handle.net/20.500.12010/15591
dc.identifierhttps://doi.org/10.1016/j.sjbs.2020.11.025
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/3498816
dc.description.abstractThe beneficial live microbes of humans and animals are termed probiotics, and the chemical compounds that improve the growth of probiotics are known as prebiotics. Paraprobiotics and postbiotics refer to dead or inactivated living cells of probiotics and healthful metabolic products that are produced by the living cells of probiotics, respectively. Although the healthful, functional, nutritional, and immune benefits of probiotics and prebiotics are scientifically well established beyond a reasonable doubt, their potential biological roles against COVID-19 infection still warrant further clinical and laboratory investigation.
dc.languageeng
dc.publisherSaudi Journal of Biological Sciences
dc.rightsinfo:eu-repo/semantics/openAccess
dc.rightsAbierto (Texto Completo)
dc.sourcereponame:Expeditio Repositorio Institucional UJTL
dc.sourceinstname:Universidad de Bogotá Jorge Tadeo Lozano
dc.subjectProbiotics
dc.subjectPrebiotics
dc.subjectParaprobiotics
dc.subjectPostbiotics
dc.subjectCOVID-19
dc.subjectSARS-CoV-2
dc.titleProbiotics, prebiotics, and COVID-19 infection: A review article


Este ítem pertenece a la siguiente institución